Background : NHS England has recommended a multidisciplinary weight manage-
| BACKG ROUND
Morbid obesity is an increasing lifelong chronic condition that no country has yet succeeded to tackle. 1 In England, the prevalence of obesity is among the highest in Europe. 2 Two-thirds of adults are overweight and one in four are obese (Body Mass Index (BMI) of >30 kg/m 2 ). 3, 4 McKinsey Global Institute reported that, second to smoking, obesity has the largest impact on the public health budget with an estimated annual cost to the United Kingdom ' s (UK) National
Health Service (NHS) of £44.7b. 5 The importance of a range of obesity prevention initiatives comes from the increasing number of health complications and their related high cost. High Blood Pressure (BP), type 2 diabetes mellitus (T2DM), heart attacks, strokes, cancers and other health issues, for instance, are evidently associated to the conditions of being overweight or obese. 4 Even though bariatric surgical intervention is a proven effective approach for treating chronic obesity, access and eligibility for bariatric surgery remains low. 6 The reasons for this are multifactorial, but may include a lack of developed infrastructure for medical assessment and services, unclear referral procedures, as well as uncertainties regarding costs and long-term outcomes. 7 In England, the rate of bariatric surgical operations dropped by 31% between 2011-2012 and 2014-2015 (from 8794 to 6032 operations, respectively). 4 It is much worse in Scotland and Wales, and there is no NHS bariatric surgery performed in Northern Ireland. 8 Provision of bariatric intervention by NHS is, therefore, less than 1% of the national need. 8 In the UK, obesity is managed through a 4-levels tiered pathway.
Tier 1 and 2 are focused on universally environmental and population-wide prevention services. 4, 9 Following this, individuals with more complex obesity and/or medical needs are considered for Tier 3 Multidisciplinary Weight Management Service (MWMS), 10 which may lead to a Tier 4 service for consideration of bariatric surgery. 4, 11 Tier 3 MWMS consists of a (bariatric) physician, a dietitian, a specialist nurse and a clinical psychologist with access to physical therapy. 4 All adults identified with a BMI of ≥40 kg/m 2 , or ≥35 kg/m 2 with comorbidities are eligible for bariatric surgery following assessment and input from Tier 3 services. Tier 3, in this context, could also apply to a "Weight Assessment and Management Clinic" provided by primary or secondary care. 4 Within a Tier 3 service, strategies are implemented to make critical changes about eating and physical activity habits to improve health and identify risk factors so that the planned intervention addresses and improves all elements comprehensively. 4 Screening for hormonal or genetic causes of excessive weight as well as all related comorbidities and disabilities are conducted by the bariatric physician and each individual should have their own tailored lifestyle and healthful eating advice provided by a specialist dietitian. In addition, patients are screened for signs of psychiatric comorbidities due to the well-recognized link between obesity with many psychological disorders such as anxiety, depression, self-harm and suicidal behaviours, eating disorders (such as binge eating and bulimia nervosa), borderline personality disorders, alcohol and substance misuse, childhood adversity, among others. Patients with proven effort, an adequate timeframe prescribed by the multidisciplinary team, and with right weight criteria and medically optimized for surgery, will then be advised to progress towards the Tier 4 bariatric surgical intervention. 4, 12 Although our understanding of the benefits of a Tier 3 service is growing-based on our appraisal of current literature, 11,4,13 current evidence remains fragmented and needs to be synthesized to produce a more comprehensive picture which will help to translate to a safe and cost-effective approach to the management of morbid obesity in the UK. We, therefore plan to explore the evidence base of effect magnitude on body weight loss in addition to other health- PubMed. An extended search was conducted using Google Scholar after reviewing additional studies that were included by Brown et al (2017) systematic review. 12 Terms used were related to "obesity" 
| Study selection
In this review, we use a similar pragmatic selection approach to Brown 
| Data extraction
We evaluated each of the included studies and extracted four data aspects: (a) descriptive to study design and intervention (Table S1 );
(b) sample size and demographic characteristics (Table S2 ) ; (c) assessed measurements (Table S3 ) ; and (d) health outcome records at baseline followed by points of time intervals (Tables S4-S9 
| Risk of bias assessment
Two authors (MA and UA) have independently assessed all included studies using the Cochrane Handbook for Systematic Reviews of Intervention tool. 14 They evaluated the possibility of the following bias elements: allocation sequence, allocation concealment, blinding (of participants, personnel and outcome assessors), incomplete outcome data and selective outcome for reporting or publication of data.
| RE SULTS
1,342 article abstracts were identified as potentially relevant, and after reviewing 418 in full-text, 11 articles and 2 published study abstracts met the inclusion criteria and were included in the review. The majority of included studies (95%) reported our primary outcome of interest in weight and/or BMI from the baseline records up to their study endpoint. Turner et al (2015) was the study article that did not report weight in any form at baseline; however, this study reported rates of participants who achieved ≥5% and ≥10% weight reduction at their intervention endpoint of 12 months (ie, 36% and 37%, respectively). 
| Study design
The study design ranged: one randomized controlled trial (RCT), 16 nine prospective cohort studies. [25] [26] [27] [28] [29] [30] [31] [32] [33] Five studies investigated the effect of Tier 3 services. 15, 19, 21, 22, 25 Three looked into the Glasgow and Clyde Weight Management Service (GCWMS). 24, 27, 29 Whereas the rest focused on further
MWMPs including: "TAKE-5" GCWMS, 28 Dietetic led, 17 "SLiM" SWM, 20 "Weight No More" SWM, 16 specialist health visitor programme, 26 Low-Energy Liquid Diet (LELD) food reintroduction, 18 Renal Weight Management Programme (RWMP), 23 specialist community weight reduction programme, 30 "CounterWeight" SWM, 31 Orlistat weight reduction 32 and biopsychological multidisciplinary programme. 33 Further details on study design and intervention description are in Table 1 and Table S1 .
| Risk of bias
All studies showed high risk in selection, performance, detection and attrition bias. This is because all included studies, except for the only RCT, 16 were designed as evaluation (before and after), retrospective analysis or uncontrolled prospective investigation. The risk of publication or reporting bias was low to unclear for all studies which may add to the overall reliability ( Figure 2 ). Attrition bias was evaluated high in consequence of the increased pattern of patients' drop-out rate; which was not fully investigated or discussed. that lost weight at 12 months, which was their intervention endpoint. 15 Wright et al (2012) reported weight at baseline and at six months (114.5 ± 23.4 kg and 109.4 ± 23.1 kg, P < 0.001, respectively). 19 The baseline accumulative average of weight is calculated at 117.88 kg. See Table 2 .
| Participants' characteristics
At three months, the calculated average BMI from six studies is Jennings et al (2014) was the only study to report a 10% or more weight reduction rate among participants (3.6%). 21 Details on rates are summarized in Table 3 .
At six months, 11 studies (58%) reported changes in BMI or weight (kg) or both. 16 42.40 (6) 40.73 (8) 36.67 (3) Weight (kg) 117.88 (16) 114.48 (7) 112.17 (10) 102.89 (5) 112.0 (1) 105.95 (2) Waist circmf.
126.9 (3) 125.3 (2) 120.3 (3) 118.0 (1) HbA1c (mmol/mol) 58.8 (5) 56.5 (2) 53.8 (5) 59.4 (2) FBS (mmol/L) 5.44 (1) 5.08 (1) 5.14 (1) 5.04 (1) Insulin usage (Units) 101.0 (2) 58.7 (1) 76.55 (2) 62.0
5.09 (2) 5.18 (1) 5.01 (2) 5.38 (1) BP (mmHg) Systolic 134.7 (2) 129.5 (1) 124.5 (2) 123.2 (2) Drop-out (%) 9.1 (1) 33.4 (5) 44.1 (8) 74.1 At eighteen months, Jennings et al (2014) was the only study that reported change in kilograms. 21 The mean reduction in weight was 
| Secondary outcome variables
The included studies reported secondary outcome variables in a heterogeneity that made tracking a set of health outcome variables problematic. Eight studies (42%) reported secondary health outcome variables at baseline: waist circumference, glycaemic control, lipids, BP and physical activity. 16, 17, 20, 21, 26, 28, 30, 32 Details on baseline results are in Table 2 . Table 2 ). 26 At six months, three studies (16%) reported further significant reduction in waist circumference with an average of 6.6 cm ( P < 0.001). 21, 28, 30 The waist circumference averaged at 120.3 cm.
The average reduction in HbA1c from five studies (26%) is calculated at 4.86 mmol/mol ( P < 0.05). 21, 30 Five studies reported the drop-out rate with an average of 33.4%, ranging from 18% to 60% (Table 2 ) . 20, 22, 28, 30, 32 At one year, HbA1c average results calculated from two studies (11%) was found to reclaim to the baseline calculated average (59.4 compared to 58.8 at baseline). 16, 21 Turner et al (2015), however, noted that 36% of participants reported a reduction in insulin usage. 15 Cheyette ' s (2007) participants experienced a similar reduced level of mean insulin usage as they did at three months reported a statistically significant decrease in BP with an average systolic reduction of 11.5 mmHg and in diastolic by 6.76 mmHg ( P = 0.001). 21, 26 Only one study (6%) reported physical activity with a similar level as the three-month point of intervention (scored 2.8 compared to 2.9 at three months). 21 Waist circumference remained relatively constant compared to six-months point; with a mean reported by one study 118.8 cm. 21 Eight studies reported increased drop-out rate with an average of 44.1% ranging from 15.6% to 78.3% (Table 2 ) . 18, 21, 23, [25] [26] [27] 31, 33 At eighteen and twenty-four months, there were little or no secondary outcome variables reported by any of the included studies. 39.20 (9) 43.35 (7) 47.90 (1) 44.40 (1) ≥10% weight loss 3.6 (1) 10.0 (2) 29.4 (2) 26.0 (1) 20.0 (2) ≥5 kg weight loss 27.20 (2) 39.21 (2) 40.90 (2) 13.60 (1) ≥10 kg weight loss 36.0 (1) a Superscript in-brackets numbers represent count of studies contributed in calculating the correlated average.
T A B L E 3 Calculated average rates of participants who have lost weight covered and reported by the included studies (%)
Drop-out rate increased to an average of 74.13% at two years point; ranging from 62.0% to 80.5%, as reported by 4 studies. 21, 29, 31, 32 
| DISCUSSION
Although obesity has an increasing acadaemic and clinical interest globally, the evidence on Tier 3 and all other MWMPs in the UK remains scarce. 4 The aim of the present review was to examine Tier (Table 3 ) .
We agree with Brown et al's (2017) review, which notes most available reviewed evidence comes from observational studies in which randomized selection and allocation into Tier 3 services would improve inference reliability. 12 The only RCT reviewed, for instance, lasted for a short intervention duration (four months) and reported a modest mean reduction in weight (2.2 kg). 16 At three months, the mean reduction in weight from all studies that reported changes (including the RCT) reached 4.11 kg, thus almost doubling the reported RCT-measured effect.
Improvements in secondary health outcome variables are significant until the effects of the drop-out rate become apparent. This may be because all studies have excluded drop-out data from their analyses at each interval. At the three-and six-months points, however, A majority of included studies were not as precise in discussing participants' reasons for dropping out. Extending efforts to assess and overcome drop-outs appeared to contribute to a successful intervention (especially a multicomponent one) and the achievement of desired targets. This is because, as anticipated by commissioning parties, Tier 3's main goal is to help patients, at a minimum, to lose weight and improve most of their quality of life aspects, improve and induce remission of comorbidities or to optimize patients' preparation for a Tier 4 bariatric surgical intervention. The goal is, optimistically, helping patients to take control of their own lives and all other healthful elements; which is the drive for commissioning all tiered weight reduction interventions.
Brown et al (2017) recently published a systematic review examining a set of criteria for interventions similar to the ones this review has covered. 12 We have only excluded two studies from their selection, as one was of non-British origin and the other was comparing groups in post-bariatric. 13, 36 They reviewed 14 studies, and our conclusions were based on lines of theoretical analysis similar to theirs. Our review adds to the evidence base on a stratified basis with summaries for weight loss achieved and calculated average outcome results and suggests further research regarding intervention ' s high drop-out rates as well as outcomes from psychological and physical activity interventions. More RCT-designed studies would greatly contribute to robust, real-life findings, as all possible confounding effects would ideally distribute evenly.
| LIMITATI ONS
Studies published on Tier 3 and UK MWMPs are limited in number.
Yet, most if not all of included studies are of high risk of bias in terms of allocation sequence, allocation concealment, blinding, incomplete outcome data. The only RCT reviewed has shown a modest change in weight compared to all included studies. 16 The high rate of dropouts was present in most if not all included studies with inadequate reasoning. The majority have excluded non-completers' data from their final analysis.
| CONCLUSION
The 
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E N D N O T E S
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